複合性局所疼痛症候群の世界市場

複合性局所疼痛症候群の世界市場は2030年までに1億1,980万米ドルに達する見込み

2024年に1億510万米ドルと推定される複合性局所疼痛症候群の世界市場は、2030年には1億1,980万米ドルに達し、分析期間2024-2030年のCAGRは2.2%で成長すると予測されます。本レポートで分析したセグメントの1つである薬剤ベース療法は、CAGR 2.5％を記録し、分析期間終了時には6,510万米ドルに達すると予測されます。脊髄刺激療法分野の成長率は、分析期間中CAGR 2.1％と推定されます。

米国市場は2,860万米ドルと推定、中国はCAGR 4.2％で成長予測

米国の複合性局所疼痛症候群市場は、2024年に2,860万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに2,260万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは4.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ0.9％と1.9％と予測されています。欧州では、ドイツがCAGR 1.3%で成長すると予測されています。

世界の複合性局所疼痛症候群市場- 主要動向と促進要因のまとめ

複合性局所疼痛症候群が臨床で注目される理由とは？

複合性局所疼痛症候群（CRPS）は慢性的で衰弱性の疼痛症状であり、一般的に手足の怪我、手術、その他の外傷後に発症します。激痛、腫脹、皮膚の色や体温の変化、運動機能障害を特徴とするCRPSは、未だ十分に理解されていないが、患者にとっては非常に苦痛な疾患です。CRPSの病態生理が複雑であることから、医学界ではCRPSの診断、治療、患者管理全般の改善にますます力を入れています。CRPSが注目されるようになった主な理由のひとつに、術後や外傷後の神経障害性疼痛の有病率の増加があります。世界中で整形外科手術、骨折、四肢損傷の件数が増加する中、CRPSの発生率は増加傾向を示しています。さらに、この疾患は初期段階で誤診されたり、見過ごされたりすることが多く、慢性疼痛や長期的な身体障害につながっています。そのため、ヘルスケアの専門家は、疾患の進行を防ぐために、集学的な疼痛管理アプローチを含む早期介入戦略を重視しています。また、専門の疼痛管理センターやCRPS専用の治療プログラムの出現も、患者ケアの向上を促しています。これらのセンターでは、薬物療法、理学療法、介入的疼痛治療などを組み合わせて、患者の予後を改善しています。さらに、患者支援団体や啓蒙キャンペーンがCRPSの病態に光を当て、診断率の向上や効果的な治療オプションの需要につながっています。

CRPSの診断と治療における進歩とは？

CRPSの診断は、決定的なバイオマーカーや標準化された診断テストがないため、依然として課題となっています。従来、臨床医がCRPSを確認する際には、臨床症状、ブダペスト基準、骨スキャンやMRIなどの画像診断技術に頼っていました。しかし、技術の進歩により診断精度が向上し、早期発見が可能になりつつあります。機能的MRI（fMRI）やサーモグラフィなどの新しい画像診断法は、CRPSに関連した神経炎症や異常な疼痛処理パターンを同定する可能性があるため、研究が進められています。薬理学的治療はCRPSの管理の要であり、新規治療薬への注目が高まっています。従来の治療法では、非ステロイド性抗炎症薬（NSAIDs）、コルチコステロイド、神経障害性疼痛治療薬（ガバペンチノイド、三環系抗うつ薬など）が用いられてきました。しかし、ケタミン静注療法、ビスフォスフォネート製剤、免疫調節薬などの新しい治療法が、CRPSに関連した疼痛や炎症を軽減する効果があるとして注目されています。脊髄刺激（SCS）や後根神経節（DRG）刺激などの介入的疼痛管理技術は、重度の難治性疼痛を有するCRPS患者の治療状況に革命をもたらしています。これらの神経調節療法は、異常な神経シグナル伝達を調節することで、標的を絞った疼痛緩和を提供し、それによって可動性と生活の質を改善します。さらに、幹細胞治療や多血小板血漿（PRP）注射などの再生医療アプローチも、損傷した神経組織を修復し、CRPSに関連する神経炎症を軽減する可能性があるとして研究が進められています。

市場動向はCRPS治療の将来をどのように形成しているのか？

個別化された疼痛管理への注目の高まりは、CRPS治療プロトコルに大きな変化をもたらしています。CRPSの症状や病状の進行が多様であることから、ヘルスケアプロバイダーは、治療に対する個々の反応に基づいて治療計画を調整する患者中心のアプローチを採用しています。このシフトは、最適な疼痛緩和を達成するために薬理学的療法、介入療法、リハビリテーション療法を組み合わせたマルチモーダル疼痛管理戦略の統合につながっています。CRPS管理におけるデジタルヘルスソリューションの役割も拡大しています。遠隔医療プラットフォームやモバイルヘルスアプリケーションは、CRPS患者の遠隔疼痛相談、自己管理プログラム、仮想理学療法セッションを可能にしています。これらのデジタル介入は、移動に制限のある患者にとって特に有益であり、頻繁に病院を訪れることなく、継続的にケアを受けることができます。さらに、ウェアラブル疼痛モニタリングデバイスの統合は、臨床医がリアルタイムで疼痛の変動や治療効果を評価するのに役立っています。CRPSに対する規制の進展と研究資金の増加が、市場の成長にさらに寄与しています。政府やヘルスケア機関はCRPSの研究改善の必要性を認識しており、新薬候補や革新的な治療アプローチを模索する臨床試験につながっています。その他の特典として、CRPSが障害給付プログラムや保険適用範囲に含まれるようになったことで、患者の治療へのアクセシビリティが向上し、先進的な治療に対する需要が高まっています。

市場を刺激する主な成長要因は何か？

複合性局所疼痛症候群市場の成長は、神経調節療法の進歩、認知度の向上と早期診断、デジタルヘルスソリューションの拡大など、いくつかの要因によってもたらされます。主な成長要因の1つは、慢性疼痛を抱えるCRPS患者にとって非常に有効であることが証明されつつある介入的疼痛管理技術、特に脊髄刺激や後根神経節刺激の採用が増加していることです。これらの手技は、長期的な疼痛緩和効果があり、オピオイド薬への依存を減らすことができるため、支持を集めています。製薬会社や医療機器メーカーによる研究開発の活発化も、もう一つの大きな成長要因です。新薬製剤、生物学的製剤、神経調節技術を評価する臨床試験が進行中であることから、CRPS治療の展望は大きな進展を遂げるものと予想されます。幹細胞を用いた治療法を含む再生医療への関心の高まりも、CRPS患者の神経修復と疼痛緩和の新たな可能性を開いています。集学的疼痛管理センターの拡大が市場成長をさらに促進しています。ヘルスケアプロバイダーは、従来の薬物療法に加えて、理学療法、心理的サポート、ライフスタイルへの介入を統合することで、CRPS治療への全体的アプローチを重視しています。このような包括的なアプローチは患者の予後を改善し、医療機関全体でCRPSに特化した治療プロトコルの採用を増やしています。さらに、デジタルヘルス介入の台頭により、患者のエンゲージメントと治療アドヒアランスが向上しています。遠隔医療プラットフォーム、ウェアラブル疼痛モニタリング機器、AIを活用した疼痛管理ツールは、個別化された知見と遠隔治療ソリューションを提供することで、CRPSケアに革命をもたらしています。テクノロジーが疼痛管理の展望を再構築し続ける中、CRPSの高度治療に対する需要は今後数年で急増すると予想されます。

これらの要因が総合的に複合性局所疼痛症候群市場の将来を形成しており、技術革新、進化する治療パラダイム、専門的なCRPS治療へのアクセスの増加により、業界は大きく成長する態勢を整えています。

セグメント

治療タイプ（薬物療法、脊髄刺激療法、外科的交感神経切除療法、その他の治療タイプ）、疾患タイプ（CRPS i疾患、CRPS II疾患、CRPS-NOS疾患）、流通チャネル（病院薬局流通チャネル、ドラッグストア流通チャネル、小売薬局流通チャネル、オンライン薬局流通チャネル）

調査対象企業の例

• Abbott Laboratories
• Axovant Gene Therapies Ltd.
• Biogen Inc.
• Biopharmaceutical Research Company（BRC）
• Boston Scientific Corporation
• Collegium Pharmaceutical
• Eli Lilly and Company
• Grunenthal Group
• Johnson & Johnson Services, Inc.
• Mallinckrodt Pharmaceuticals
• Medtronic
• NeurogesX
• Nevro Corp.
• Pfizer Inc.
• PharmaTher Holdings Ltd.
• Purdue Pharma
• Sandoz
• Soin Therapeutics
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Complex Regional Pain Syndrome Market to Reach US$119.8 Million by 2030

The global market for Complex Regional Pain Syndrome estimated at US$105.1 Million in the year 2024, is expected to reach US$119.8 Million by 2030, growing at a CAGR of 2.2% over the analysis period 2024-2030. Drugs-based Therapy, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$65.1 Million by the end of the analysis period. Growth in the Spinal Cord Stimulation Therapy segment is estimated at 2.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$28.6 Million While China is Forecast to Grow at 4.2% CAGR

The Complex Regional Pain Syndrome market in the U.S. is estimated at US$28.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$22.6 Million by the year 2030 trailing a CAGR of 4.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 1.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.3% CAGR.

Global Complex Regional Pain Syndrome Market - Key Trends & Drivers Summarized

Why Is Complex Regional Pain Syndrome Gaining Increased Clinical Attention?

Complex Regional Pain Syndrome (CRPS) is a chronic and debilitating pain condition that typically develops after an injury, surgery, or other trauma to the limbs. Characterized by severe pain, swelling, changes in skin color and temperature, and motor dysfunction, CRPS remains a poorly understood yet highly distressing condition for patients. Given the complexity of its pathophysiology, the medical community has been increasingly focused on improving its diagnosis, treatment, and overall patient management. One of the primary reasons for the growing attention toward CRPS is the increasing prevalence of post-surgical and post-traumatic neuropathic pain. With a rising number of orthopedic surgeries, fractures, and limb injuries worldwide, the incidence of CRPS has shown an upward trend. Moreover, the condition is often misdiagnosed or overlooked in its early stages, leading to chronic pain and long-term disability. Consequently, healthcare professionals are emphasizing early intervention strategies, including multidisciplinary pain management approaches, to prevent disease progression. The emergence of specialized pain management centers and dedicated CRPS treatment programs is also facilitating better patient care. These centers employ a combination of pharmacological therapies, physical therapy, and interventional pain procedures to improve patient outcomes. Additionally, patient advocacy groups and awareness campaigns are shedding light on the condition, leading to increased diagnosis rates and demand for effective therapeutic options.

What Are the Advancements in CRPS Diagnosis and Treatment?

The diagnosis of CRPS remains a challenge due to the lack of definitive biomarkers and standardized diagnostic tests. Traditionally, clinicians rely on clinical symptoms, the Budapest criteria, and diagnostic imaging techniques such as bone scans and MRI to confirm CRPS. However, technological advancements are improving diagnostic accuracy and enabling earlier detection. Emerging imaging modalities, such as functional MRI (fMRI) and thermography, are being explored for their potential in identifying CRPS-related neuroinflammation and abnormal pain processing patterns. Pharmacological treatment remains a cornerstone of CRPS management, with a growing focus on novel therapeutic agents. Traditional treatment approaches involve the use of nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and neuropathic pain medications such as gabapentinoids and tricyclic antidepressants. However, newer therapies, including intravenous ketamine infusions, bisphosphonates, and immune-modulating drugs, are gaining attention for their efficacy in reducing CRPS-associated pain and inflammation. Interventional pain management techniques, such as spinal cord stimulation (SCS) and dorsal root ganglion (DRG) stimulation, have revolutionized the treatment landscape for CRPS patients with severe and refractory pain. These neuromodulation therapies provide targeted pain relief by modulating abnormal nerve signaling, thereby improving mobility and quality of life. Additionally, regenerative medicine approaches, including stem cell therapy and platelet-rich plasma (PRP) injections, are being investigated for their potential in repairing damaged nerve tissues and reducing neuroinflammation associated with CRPS.

How Are Market Trends Shaping the Future of CRPS Treatment?

The increasing focus on personalized pain management is driving significant changes in CRPS treatment protocols. Given the heterogeneity of CRPS symptoms and disease progression, healthcare providers are adopting a patient-centric approach that tailors treatment plans based on individual responses to therapy. This shift is leading to the integration of multimodal pain management strategies, combining pharmacological, interventional, and rehabilitative therapies to achieve optimal pain relief. The role of digital health solutions in CRPS management is also expanding. Telemedicine platforms and mobile health applications are enabling remote pain consultations, self-management programs, and virtual physical therapy sessions for CRPS patients. These digital interventions are particularly beneficial for individuals with mobility limitations, ensuring continuous access to care without frequent hospital visits. Moreover, the integration of wearable pain monitoring devices is helping clinicians assess pain fluctuations and treatment efficacy in real time. Regulatory advancements and increased research funding for CRPS are further contributing to market growth. Governments and healthcare organizations are recognizing the need for improved CRPS research, leading to clinical trials exploring novel drug candidates and innovative treatment approaches. Additionally, the inclusion of CRPS in disability benefit programs and insurance coverage is improving treatment accessibility for patients, thereby driving demand for advanced therapies.

What Are the Key Growth Drivers Fueling the Market?

The growth in the Complex Regional Pain Syndrome market is driven by several factors, including advancements in neuromodulation therapies, increasing awareness and early diagnosis, and the expansion of digital health solutions. One of the primary growth drivers is the rising adoption of interventional pain management techniques, particularly spinal cord stimulation and dorsal root ganglion stimulation, which are proving to be highly effective for CRPS patients with chronic pain. These procedures are gaining traction due to their long-term pain relief benefits and reduced dependence on opioid medications. The increasing research and development efforts by pharmaceutical companies and medical device manufacturers are another major growth factor. With ongoing clinical trials evaluating new drug formulations, biologics, and neuromodulation technologies, the CRPS treatment landscape is expected to witness significant advancements. The growing interest in regenerative medicine, including stem cell-based therapies, is also opening new possibilities for nerve repair and pain relief in CRPS patients. The expansion of multidisciplinary pain management centers is further driving market growth. Healthcare providers are emphasizing a holistic approach to CRPS treatment by integrating physical therapy, psychological support, and lifestyle interventions alongside conventional pharmacotherapy. This comprehensive approach is improving patient outcomes and increasing the adoption of CRPS-specific treatment protocols across healthcare institutions. Additionally, the rise of digital health interventions is enhancing patient engagement and treatment adherence. Telehealth platforms, wearable pain monitoring devices, and AI-powered pain management tools are revolutionizing CRPS care by offering personalized insights and remote therapeutic solutions. As technology continues to reshape the pain management landscape, the demand for advanced CRPS treatments is expected to surge in the coming years.

With these factors collectively shaping the future of the Complex Regional Pain Syndrome market, the industry is poised for significant growth, driven by technological innovations, evolving treatment paradigms, and increasing accessibility to specialized CRPS therapies.

SCOPE OF STUDY:

The report analyzes the Complex Regional Pain Syndrome market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Therapy Type (Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy, Other Therapy Types); Disease Type (CRPS I Disease, CRPS II Disease, CRPS-NOS Disease); Distribution Channel (Hospital Pharmacies Distribution Channel, Drug Stores Distribution Channel, Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Abbott Laboratories
• Axovant Gene Therapies Ltd.
• Biogen Inc.
• Biopharmaceutical Research Company (BRC)
• Boston Scientific Corporation
• Collegium Pharmaceutical
• Eli Lilly and Company
• Grunenthal Group
• Johnson & Johnson Services, Inc.
• Mallinckrodt Pharmaceuticals
• Medtronic
• NeurogesX
• Nevro Corp.
• Pfizer Inc.
• PharmaTher Holdings Ltd.
• Purdue Pharma
• Sandoz
• Soin Therapeutics
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Complex Regional Pain Syndrome - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Clinical Awareness and Diagnosis Rates Drive Demand for Targeted CRPS Therapies
  • OEM Innovations in Nerve Blocks and Neuromodulation Expand Interventional Treatment Options
  • Growing Use of Multimodal Pain Management Strategies Supports Adoption of Combination Therapies
  • Expansion of Physical Rehabilitation and Occupational Therapy Programs Enhances Non-Pharmacologic Management
  • Rising Investment in CRPS Research and Clinical Trials Accelerates Drug Pipeline Activity
  • OEM Development of Intrathecal Drug Delivery Systems Enhances Localized Pain Control
  • Integration of Telehealth and Remote Pain Assessment Tools Expands Access to Specialized Care
  • Growing Emphasis on Early Diagnosis and Functional Recovery Supports Holistic Treatment Approaches
  • OEM Focus on Cannabinoid and NMDA Antagonist Therapies Drives Novel Drug Development
  • Surging Patient Advocacy and Education Campaigns Improve Treatment-Seeking Behavior
  • Expansion of Biologics and Regenerative Therapies for Nerve Repair Fuels Market Innovation
  • OEM Collaboration With Pain Management Clinics Accelerates Adoption of Interventional Techniques
  • Increasing Insurance Coverage and Reimbursement for CRPS Therapies Enhances Access
  • Use of Wearable Pain Monitoring Devices Enables Personalized and Continuous Care Plans
  • Rising Interest in Non-Invasive Neuromodulation Solutions Encourages Home-Based Management
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Complex Regional Pain Syndrome Market Analysis of Annual Sales in US$ for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Complex Regional Pain Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Complex Regional Pain Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Drugs-based Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Drugs-based Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Drugs-based Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Spinal Cord Stimulation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Spinal Cord Stimulation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Spinal Cord Stimulation Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Surgical Sympathectomy Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Surgical Sympathectomy Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Surgical Sympathectomy Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Therapy Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Therapy Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other Therapy Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Retail Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Online Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Online Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Online Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Hospital Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Drug Stores Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Drug Stores Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Drug Stores Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for CRPS I Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for CRPS I Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for CRPS I Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for CRPS II Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for CRPS II Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for CRPS II Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for CRPS-NOS Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for CRPS-NOS Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for CRPS-NOS Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• JAPAN
  • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• CHINA
  • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 65: China Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• EUROPE
  • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Complex Regional Pain Syndrome by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Complex Regional Pain Syndrome by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• FRANCE
  • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 86: France Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• GERMANY
  • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 113: UK Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Complex Regional Pain Syndrome by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Complex Regional Pain Syndrome by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• INDIA
  • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 170: India Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Complex Regional Pain Syndrome by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Complex Regional Pain Syndrome by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Complex Regional Pain Syndrome by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Complex Regional Pain Syndrome by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030
• AFRICA
  • Complex Regional Pain Syndrome Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Complex Regional Pain Syndrome by Therapy Type - Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Complex Regional Pain Syndrome by Therapy Type - Percentage Breakdown of Value Sales for Drugs-based Therapy, Spinal Cord Stimulation Therapy, Surgical Sympathectomy Therapy and Other Therapy Types for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Complex Regional Pain Syndrome by Distribution Channel - Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Complex Regional Pain Syndrome by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel, Hospital Pharmacies Distribution Channel and Drug Stores Distribution Channel for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Complex Regional Pain Syndrome by Disease Type - CRPS I Disease, CRPS II Disease and CRPS-NOS Disease Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Complex Regional Pain Syndrome by Disease Type - Percentage Breakdown of Value Sales for CRPS I Disease, CRPS II Disease and CRPS-NOS Disease for the Years 2015, 2025 & 2030

IV. COMPETITION